WGS · GeneDx Holdings Corp.
$56.15
-16.37% last session
End-of-day data · close of 2026-10-23
Market cap
$2B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
46.9
Dividend yield
0.0%
Beta
1.97
Avg volume
1M
Employees
1K
Daily Change %
-16.37%
5 Days Change
5.55%
10 Days Change
3.36%
30 Days Change
-21.20%
60 Days Change
-21.19%
Month to Day Change
-5.38%
Year to Day Change
-48.38%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — WGS
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-01
Latest call per bank · past 12 months
Wells Fargo
Overweight$75.00
+33.6% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-01 | Guggenheim | Maintains | Buy | $74.00 → $83.00 |
| 2026-08-04 | Canaccord Genuity | Maintains | Buy | $75.00 → $90.00 |
| 2026-08-04 | BTIG | Reiterates | Buy | $90.00 |
| 2026-06-29 | Guggenheim | Maintains | Buy | $70.00 → $74.00 |
| 2026-06-23 | Piper Sandler | Maintains | Overweight | $50.00 → $63.00 |
| 2026-05-05 | Canaccord Genuity | Maintains | Buy | $100 → $75.00 |
| 2026-05-05 | Wells Fargo | Maintains | Overweight | $155 → $75.00 |
| 2026-05-05 | Guggenheim | Maintains | Buy | $100 → $70.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 31 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 30.1% below the 50-day MA ($80.35).
- bearish: Price vs 200-day MA: Trading 23.4% below the 200-day MA ($73.32).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bearish: MACD (12,26,9): MACD histogram is negative (-0.46) — short-term momentum is fading.
- neutral: 52-week range: Price sits between the 52-week low ($34.51) and high ($167.51).
WGS Price Chart
Loading chart for WGS…
Fundamentals
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$249B 17.1% YTD
DHR
Danaher Corporation
$162B 1.0% YTD
NTRA
Natera, Inc.
$58B 75.2% YTD
A
Agilent Technologies, Inc.
$49B 28.7% YTD
IQV
IQVIA Holdings, Inc.
$46B 23.5% YTD
WAT
Waters Corporation
$45B 20.0% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -16.2% YTD
ILMN
Illumina, Inc.
$41B 105.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.